Bicaudate diameter—the most specific and simple CT parameter in the diagnosis of Huntington's disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuroradiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00328198PMID 6234475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic value of CT in patients with huntington's chorea and their offspring

  2004cited by this paper
• A PROPOSAL FOR A UNIFORM MINIMAL RECORD OF DISABILITY IN MULTIPLE SCLEROSIS

  1981cited by this paper
• Huntington disease

  1981cited by this paper
• COMPUTED AXIAL TOMOGRAPHY IN HUNTINGTON'S DISEASE AND PERSONS AT‐RISK FOR HUNTINGTON'S DISEASE

  1980cited by this paper
• Huntington disease

  1979cited by this paper
• BICAUDATE INDEX IN COMPUTERIZED TOMOGRAPHY OF HUNTINGTON DISEASE AND CEREBRAL ATROPHY

  1979cited by this paper
• The Evans ratio for ventricular size: A calculation error

  1979cited by this paper
• Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy

  1978cited by this paper
• Computed tomography for Huntington's disease

  1977cited by this paper
• Frontal ventricular dimensions on normal computed tomography.

  1976cited by this paper
• Morphometric studies of the neuropathological changes in choreatic diseases.

  1976cited by this paper
• AN ENCEPHALOGRAPHIC RATIO FOR ESTIMATING VENTRICULAR ENLARGEMENT AND CEREBRAL ATROPHY

  1942cited by this paper

• Reading Between the Striatal Lines: Magnetic Resonance Imaging Insights Into Huntington Disease

  2025cites this paper
• Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

  2020cites this paper
• HUNTINGTON’S DISEASE: GENETIC MODIFIERS OF AGE AT ONSET AND PATHOLOGICAL BIOMARKERS

  2017cites this paper
• Maladie de Huntington à début tardif à propos d'une série de 23 cas

  2015cites this paper
• Classification in psychiatry: from a symptom based to a cause based model?

  2015cites this paper
• Imaging in Huntington’s Disease and Other Choreas

  2013cites this paper
• FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2013cites this paper
• 3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

  2011cites this paper
• Transcranial sonography in Huntington's disease.

  2010cites this paper
• Spectrum of tardive syndromes: clinical recognition and management

  2010cites this paper
• 3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future

  2010cites this paper
• Tetrabenazine in Huntington’s Disease Chorea

  2009cites this paper
• Fortschritte in Früh- und Verlaufsdiagnostik bei Morbus Huntington

  2009cites this paper
• Cella media distance in human brain in relation to age and gender.

  2009cites this paper
• Huntington's disease

  2007cites this paper
• Huntington's disease.

  2007cites this paper
• Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies

  2006cites this paper
• Eine epidemiologische Studie im süddeutschen Raum

  2004cites this paper
• Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?

  2004cites this paper
• Measurement of caudate nucleus area —A more accurate measurement for Huntington's disease?

  2004cites this paper
• Differential Effect of Right and Left Basal Ganglionic Infarctions on Procedural Learning

  2004cites this paper
• Computerized tomography in amyotrophic choreo-acanthocytosis

  2004cites this paper
• Assessment of complex movements reflects dysfunction in Huntington’s disease

  2003influential citation
• Increased glutamate in CSF and plasma of patients with HIV dementia.

  2002cites this paper
• FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2002cites this paper
• Increased glutamate in CSF and plasma of patients with HIV dementia

  2001cites this paper
• Neurophysiological abnormalities in the westphal variant of Huntington's disease

  1998cites this paper
• 3-Nitropropionic acid animal model and Huntington's disease.

  1997cites this paper
• Longitudinal change in basal ganglia volume in patients with Huntington's disease

  1997cites this paper
• Implicit memory in parkinsonian patients: evidence for deficient skill learning.

  1996cites this paper
• Huntington's disease: a molecular genetic and CT comparison.

  1996cites this paper
• Juvenile Huntington disease: CT and MR features.

  1995cites this paper
• Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.

  1995cites this paper
• Huntington's disease in a Sudanese family from Khartoum

  1995influential citation
• Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons

  1994cites this paper
• Huntington's disease in two unrelated Arab kindreds and in an Afghani family resident in Saudi Arabia.

  1994cites this paper
• [Early and presymptomatic detection of Huntington chorea].

  1993cites this paper
• Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of huntington's disease

  1993cites this paper
• Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

  1992cites this paper
• Patterns of cerebral atrophy in HIV–1–infected individuals

  1992cites this paper
• Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

  1992cites this paper
• The use of positron emission tomography in the clinical assessment of dementia.

  1992cites this paper
• The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans.

  1991cites this paper
• Bicaudate ratio as a measure of caudate volume on MR images.

  1991cites this paper
• Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

  1990cites this paper
• A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

  1990cites this paper
• CT brainstem abnormalities in the differential diagnosis of Huntington's disease.

  1990cites this paper
• Procedural memory in Parkinson's disease: impaired motor but not visuoperceptual learning.

  1990cites this paper
• A controlled clinical trial of baclofen as protective therapy in early huntington's disease

  1989cites this paper
• Neumutation bei Huntingtonscher Krankheit — Neurologische und humangenetische Kriterien zur Diagnosestellung

  1989cites this paper
• The quinolinic acid model of Huntington's disease: locomotor abnormalities.

  1989cites this paper
• Hand muscle reflexes following electrical stimulation in choreatic movement disorders.

  1989cites this paper
• New mutation to Huntington's disease.

  1989cites this paper
• Clinical‐pathologic correlation in Huntington's disease

  1989cites this paper
• [New aspects of Huntington disease. The neurotoxin hypothesis, genetic diagnosis and psychological sequelae].

  1988cites this paper
• Neuroradiologische Diagnostik bei Huntingtonscher Krankheit

  1988cites this paper
• Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.

  1988cites this paper
• Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease

  1988cites this paper
• Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.

  1988cites this paper
• Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.

  1987cites this paper
• Normal caudate glucose metabolism in persons at risk for Huntington's disease.

  1987cites this paper
• Controlling for Cerebral Atrophy in Positron Emission Tomography Data

  1987cites this paper
• Huntington's disease in Venezuela

  1986cites this paper
• PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline

  1986cites this paper
• Positron emission tomography in the early diagnosis of Huntington's disease

  1986cites this paper